Finally, the clinical implication of DDX27 was assessed in three independent CRC cohorts, which demonstrated that high expression of DDX27 predicts adverse prognosis in CRC patients, consistent with its putative pro-tumorigenic role in CRC. This evidence concerns the gene DDX27 and colorectal carcinoma.